Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (301-310 of 664) with videos related to

Pageof 67
Sort By:
JCO Precision Oncology|June 29, 2023
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-AnalysisUlrik Lassen, Carsten Bokemeyer, Jesus Garcia-Foncillas, et al.
International Journal of Clinical and Experimental Pathology|September 5, 2015
High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancerTim Hanke, Nathaniel Melling, Ronald Simon, et al.
Molecular Cancer|November 22, 2013
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathwayLeticia Oliveira-Ferrer, Jasmin Wellbrock, Udo Bartsch, et al.
Thrombosis and Haemostasis|December 17, 2013
Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretionFlorian Langer, Tobias Obser, Florian Oyen, et al.
Cancers|August 27, 2021
Bacitracin and Rutin Regulate Tissue Factor Production in Inflammatory Monocytes and Acute Myeloid Leukemia BlastsLennart Beckmann, Christina Charlotte Rolling, Minna Voigtländer, et al.
Oncotarget|April 28, 2016
Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinomaFriederike Braig, Minna Voigtlaender, Aneta Schieferdecker, et al.
Targeted Oncology|June 17, 2025
Streamlining and Accelerating the Molecular Tumor Board Process at the University Medical Center Hamburg-EppendorfLayla Tabea Riemann, Maximilian Ataian, Felicia P S Hähner, et al.
Cancer Letters|March 13, 2018
BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapyChristoph Oing, Pierre Tennstedt, Ronald Simon, et al.
Oncotarget|April 19, 2017
Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemiaEmily-Marie Latuske, Hauke Stamm, Marianne Klokow, et al.
BMC Pulmonary Medicine|April 28, 2017
Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertensionLars Harbaum, Kaaja M Baaske, Marcel Simon, et al.
Pageof 67

Showing results (301-310 of 664) with videos related to

Sort By:
Pageof 67
JCO Precision Oncology|June 29, 2023
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-AnalysisUlrik Lassen, Carsten Bokemeyer, Jesus Garcia-Foncillas, et al.
International Journal of Clinical and Experimental Pathology|September 5, 2015
High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancerTim Hanke, Nathaniel Melling, Ronald Simon, et al.
Molecular Cancer|November 22, 2013
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathwayLeticia Oliveira-Ferrer, Jasmin Wellbrock, Udo Bartsch, et al.
Thrombosis and Haemostasis|December 17, 2013
Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretionFlorian Langer, Tobias Obser, Florian Oyen, et al.
Cancers|August 27, 2021
Bacitracin and Rutin Regulate Tissue Factor Production in Inflammatory Monocytes and Acute Myeloid Leukemia BlastsLennart Beckmann, Christina Charlotte Rolling, Minna Voigtländer, et al.
Oncotarget|April 28, 2016
Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinomaFriederike Braig, Minna Voigtlaender, Aneta Schieferdecker, et al.
Targeted Oncology|June 17, 2025
Streamlining and Accelerating the Molecular Tumor Board Process at the University Medical Center Hamburg-EppendorfLayla Tabea Riemann, Maximilian Ataian, Felicia P S Hähner, et al.
Cancer Letters|March 13, 2018
BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapyChristoph Oing, Pierre Tennstedt, Ronald Simon, et al.
Oncotarget|April 19, 2017
Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemiaEmily-Marie Latuske, Hauke Stamm, Marianne Klokow, et al.
BMC Pulmonary Medicine|April 28, 2017
Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertensionLars Harbaum, Kaaja M Baaske, Marcel Simon, et al.
Pageof 67